A Food-Derived Flavonoid Luteolin Protects against Angiotensin II-Induced Cardiac Remodeling

PloS One
Atsuko NakayamaIssei Komuro

Abstract

Oxidative stress has been implicated in cardiac remodeling (cardiac fibrosis and hypertrophy), which impairs cardiac function and metabolism; therefore, it is anticipated antioxidative compounds will have protective properties against cardiac remodeling. Luteolin (3',4',5,7-tetrahydroxyflavone), a widely distributed flavonoid found in many herbal extracts including celery, green pepper, perilla leaves and seeds, and chamomile, is a known to be a potent antioxidant and was previously demonstrated to exert an antifibrotic effect in the lungs and the liver. In this study, we clearly demonstrate that oral pretreatment with the higher-luteolin diet (0.035% (wt/wt)) protected against cardiac fibrosis and hypertrophy as well as a hyperoxidative state in Ang II-infused rats. In cardiac tissue, increased gene expression levels of TGFβ1, CTGF, Nox2, Nox4, ANP, and BNP induced by Ang II were restored by oral pretreatment of this high-luteolin diet. In cultured rat cardiac fibroblasts, H2O2-induced TGFβ1 expression and the phosphorylation of JNK were suppressed by luteolin pretreatment. In conclusion, food-derived luteolin has protective actions against Ang II-induced cardiac remodeling, which could be mediated through attenuation of oxida...Continue Reading

References

Nov 13, 2001·Current Opinion in Cardiology·J DíezR Querejeta
Dec 14, 2002·Circulation Research·Ichiro ManabeRyozo Nagai
Dec 31, 2002·Journal of Molecular and Cellular Cardiology·Claude Delcayre, Bernard Swynghedauw
Dec 4, 2003·Journal of the American College of Cardiology·Tzu-Hurng ChengJin-Jer Chen
Feb 18, 2004·Hypertension·Fumitaka KuwaharaTsutomu Imaizumi
May 1, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Andrew Leask, David J Abraham
Jul 28, 2004·Cardiovascular Research·Stephan Rosenkranz
Dec 29, 2004·Cardiovascular Research·Patrizia CamellitiPeter Kohl
Feb 21, 2006·Journal of the American College of Cardiology·Ali J MarianRaffaella Lombardi
Dec 28, 2006·Hypertension·Eiki Takimoto, David A Kass
May 10, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Danijel JuricThomas Netticadan
Jul 3, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Indroneal BanerjeeTroy A Baudino
Jul 10, 2007·The Journal of Clinical Hypertension·Javier Díez
Feb 23, 2008·The Journal of Clinical Investigation·Tatsuya MorimotoKoji Hasegawa
Jul 3, 2008·Journal of Agricultural and Food Chemistry·O Benavente-García, J Castillo
Jan 7, 2009·Therapeutic Advances in Cardiovascular Disease·Christian M Werner, Michael Böhm
Mar 18, 2009·Circulation·Vernon W DolinskyJason R B Dyck
Sep 15, 2009·Toxicology and Applied Pharmacology·Robert DomitrovićIvana Sain
Dec 5, 2009·Circulation Research·Colby A SoudersTroy A Baudino
Sep 3, 2010·The Journal of Clinical Investigation·Polakit TeekakirikulJonathan G Seidman
Oct 21, 2010·Journal of Agricultural and Food Chemistry·Chiu-Yuan ChenShih-Lan Hsu
Dec 24, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Pei-Hu LiaoShiang-Suo Huang
Apr 19, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Peng ZhangUlrike Mende
Jun 16, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Tetsuro AgoTakanari Kitazono

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

Image J
SPSS
ANALYST

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.